Drug Topics - November 5, 2007 - (Page 9)

www.drugtopics.com NOVEMBER 5, 2007 DRUG TOPICS 9 Letters Pharmacists: Assert yourselves n your Oct. 8 cover story—“Are you getting pharmacy’s message across?”—you identified the passive behavior of the profession and the ineffectiveness of this approach. A further problem is that those of us who dare to openly criticize our poor treatment from government, insurance companies, academia, or Pharma are then both castigated and ostracized by the pharmacy-elected leadership—the same leadership that is unwilling to risk upsetting the entities that continue to unfairly treat the profession. At the beginning of WWII, the Prime Minister of England was Neville Chamberlain. He was a passive man who believed that striking an accord with the Axis forces would allow England to remain unharmed. We know all too well that not only was England damaged irreparably but Europe also would never be the same. Winston Churchill succeeded him. It was through his harsh resolve that he guided England, formed a strategic success plan with other Allied nations, and was successful in stemming the tide of a destructive element. The question that the pharmacy leaders should ask themselves is, When is it time to change tactics before the profession is totally decimated? Chamberlain out, Churchill in—passive behavior out and aggressive behavior in should be pharmacy’s resolve. Baseball managers make these decisions on a daily basis with pitchers. How is it that pharmacists are unable to realize a change in tactics is necessary or the day will be lost? My efforts to push pharmacy forward and past these barriers have met with disdain from within the leadership of the profession. It has been said that my direct approach to making things happen is strident. Maybe if pharmacy leadership had more resolve to push harder their agenda, the profession would not be in the quagmire it currently occupies. I pulmonary embolism (PE) as a result of DVT—more than breast cancer and AIDS combined. In the article, pharmacist Edith Nutescu noted that “only a small fraction of hospitalized medical patients receive thrombophylaxis.” The risk of PE and DVT can be prevented by at least a third if patients take a low-dose aspirin preoperatively and continued it for 35 days (Lancet 2000 Apr. 15;355;1295-1302). A WHO study showed that plane, train, bus, or auto passengers are at higher risk of DVT due to stagnation of blood and prolonged immobility, and the risk remains for four weeks. Thirty million people in the United States have peripheral artery disease (PAD), and aspirin remains the first line of defense (Heart 2007;93:303-308). Lowdose aspirin now comes in a fast-dissolving tablet, Fasprin, which dissolves in the mouth and is absorbed by the buccal mucosa. For those with PAD, and those at risk for DVT and PE, a Fasprin a day may provide a simple solution. Ed Petrus, M.D. Austin, Texas ejp.tx@sbcglobal.net Love your digital edition! I commend your magazine for going digital! I always enjoy reading the newest issue of Drug Topics when it arrives at my work and am always disappointed to have to put it into the recycling bin. In a country where far too many people are seemingly oblivious to the huge amount of waste generated daily, it is a welcome change to see your magazine take the smart step of going digital to reduce waste. The digital format is a very user-friendly design, and the zoom feature is awesome. Keep up the good work! I encourage your readers to make the switch today. Chris Wade, Pharm.D. Inpatient Hospital Pharmacist Sutter Chanate Hospital Santa Rosa, Calif. cgwade@hotmail.com Allen Nichol, Pharm.D. Director Diabetes Management Program Grandview Family Practice Columbus, Ohio Allen.Nichol@odh.ohio.gov Aspirin can help DVT According to the Special Report in your Sept. 17 issue, an estimated two million people suffer annually from deep vein thrombosis (DVT), and 300,000 die from a For the record: In the Sept. 17 “Clinical Twisters,” one of our respondents inadvertently misplaced a decimal point. We regret that our editing staff did not catch this before the column appeared in print. The correct adult dose for digoxin is 0.125 mg daily when renal function is normal. Letters (including e-mail) should be as brief as possible and sent with the writer’s name, address, daytime phone number, and date of the issue you are referencing to: Editor, Drug Topics, 123 Tice Boulevard, Woodcliff Lake, N.J. 07677-7664. E-mail address: drugtopics@advanstar.com. Correspondence may be edited for length and clarity. http://www.drugtopics.com

Table of Contents Feed for the Digital Edition of Drug Topics - November 5, 2007

Drug Topics - November 5, 2007 Contents Latebreakers Latebreakers in Depth Letters Rx Care Community Practice 150 Years of American Pharmacy Hospital Practice Pharmacists at Risk Government and Law High-Density Lipoprotein New Products Advertisers Index Classified Viewpoint

Drug Topics - November 5, 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.